You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Nasal Cavity and Paranasal Sinus Poorly

Recruiting
  • Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 23, 2021

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

Recruiting
  • Squamous Cell Carcinoma of Oral Cavity
  • +3 more
  • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
  • Gliwice, Silesia, Poland
    The Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023

Squamous Cell Carcinoma, the Nasal Cavity, Paranasal Sinuses Trial in Houston (Pembrolizumab, Docetaxel, Cisplatin)

Recruiting
  • Squamous Cell Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +24 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 6, 2022

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA

Withdrawn
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
  • +6 more
  • hypofractionated radiation therapy
  • +3 more
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

Active, not recruiting
Has Results
  • Squamous Cell Carcinoma of the Oropharynx
  • +7 more
  • Tampa, Florida
  • +2 more
Dec 30, 2022

Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • +4 more
  • Near Infrared Imaging
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 5, 2022

Head Neck Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous

Completed
Has Results
  • Head and Neck Cancer
  • +19 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Mar 6, 2020

Lung Squamous Cell Carcinoma Trial in Yancheng (To explore the efficacy and safety of immune checkpoint inhibitor combined with

Recruiting
  • Lung Squamous Cell Carcinoma
  • To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).
  • Yancheng, Jiangsu, China
    Yancheng Clinical College of Xuzhou Medical University
Mar 21, 2023

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Oral Cavity Squamous Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +57 more
  • placebo
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 18, 2020

Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Centerl
Apr 25, 2023

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

Recruiting
  • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +4 more
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

Recruiting
  • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +28 more
  • San Francisco, California
    University of California, San Francisco
Dec 16, 2022

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell

Active, not recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +19 more
  • Duarte, California
  • +18 more
Aug 24, 2022

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • KEYTRUDA®
  • (no location specified)
Nov 17, 2023

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Not yet recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +10 more
  • (no location specified)
Jan 31, 2023

Recurrent Colon Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma Trial

Completed
  • Recurrent Colon Carcinoma
  • +41 more
  • Cetuximab
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 12, 2020

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +23 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
  • +1 more
Jul 7, 2022